BR0303367A - Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose - Google Patents

Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose

Info

Publication number
BR0303367A
BR0303367A BR0303367-8A BR0303367A BR0303367A BR 0303367 A BR0303367 A BR 0303367A BR 0303367 A BR0303367 A BR 0303367A BR 0303367 A BR0303367 A BR 0303367A
Authority
BR
Brazil
Prior art keywords
mycobacterium
cells
surfactant
pharmaceutical
tuberculosis
Prior art date
Application number
BR0303367-8A
Other languages
English (en)
Inventor
Bakulesh Mafatlal Khamar
Rajiv Indravadan Modi
Original Assignee
Bakulesh Mafatlal Khamar
Rajiv Indravadan Modi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bakulesh Mafatlal Khamar, Rajiv Indravadan Modi filed Critical Bakulesh Mafatlal Khamar
Publication of BR0303367A publication Critical patent/BR0303367A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"CéLULAS DE MYCOBACTERIUM W, VEìCULO FARMACEUTICAMENTE ACEITáVEL, PRESERVATIVO, RUPTURA DE MYCOBACTERIUM W, EXTRAçãO DE SOLVENTE, ENZIMAS USADAS PARA A EXTRAçãO ENZIMáTICA DE CéLULAS DE MYCOBACTERIUM W, ADJUVANTE, COMPOSIçãO FARMACêUTICA, TENSOATIVO, E, CONCENTRAçãO DE TENSOATIVO DO PROCESSO DE FABRICAR UMA COMPOSIçãO FARMACêUTICA PARA A ADMINISTRAçãO DE TUBERCULOSE". A invenção refere-se ao processo para a preparação de formulações compreendendo um microorganismo Mycobacterium w para o tratamento de tuberculose.
BR0303367-8A 2002-03-08 2003-03-04 Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose BR0303367A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN236MU2002 2002-03-08
PCT/IB2003/000801 WO2003075824A2 (en) 2002-03-08 2003-03-04 Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Publications (1)

Publication Number Publication Date
BR0303367A true BR0303367A (pt) 2004-07-20

Family

ID=27799868

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0303367-8A BR0303367A (pt) 2002-03-08 2003-03-04 Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose

Country Status (5)

Country Link
JP (1) JP2005519941A (pt)
KR (1) KR20050008453A (pt)
AU (1) AU2003209533A1 (pt)
BR (1) BR0303367A (pt)
WO (1) WO2003075824A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
GB2400560A (en) * 2002-01-29 2004-10-20 Rajiv Indravadan Modi Method of providing prophylaxis for tuberculosis in hiv positive individuals
CA2681420A1 (en) * 2007-03-20 2008-09-25 Cadila Pharmaceuticals Limited P38 inhibitors
JP5713672B2 (ja) 2007-04-12 2015-05-07 ジェニファー ライター， 結核のワクチンおよびその使用方法
EP2170083A4 (en) * 2007-06-28 2011-09-28 Cadila Pharmaceuticals Ltd PROTEIN KINASE ACTIVATED BY A MITOGENIC MODULATOR
FR2979826B1 (fr) * 2011-09-08 2013-12-27 Univ Bordeaux Segalen Composition anti-inflammatoire
KR101696514B1 (ko) * 2014-08-18 2017-01-24 서울대학교산학협력단 신규한 온도 민감성 마이코박테리아 균주 및 이를 포함하는 마이코박테리아 감염증에 대한 백신 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567585A (en) * 1963-07-12 1971-03-02 Ciba Geigy Corp Process for obtaining bcg-cultures
JPS4843842B1 (pt) * 1970-07-17 1973-12-21

Also Published As

Publication number Publication date
JP2005519941A (ja) 2005-07-07
WO2003075824A3 (en) 2003-12-24
AU2003209533A1 (en) 2003-09-22
WO2003075824A2 (en) 2003-09-18
AU2003209533A8 (en) 2003-09-22
KR20050008453A (ko) 2005-01-21

Similar Documents

Publication Publication Date Title
BRPI0409185A (pt) formulações veterinárias anti-helmìnticas tópicas
ATE292959T1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
BRPI0408165A (pt) processos para melhorar a atividade das enzimas de degradação de lignocelulose
AU3262597A (en) Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
NO941937L (no) Sakarinderivater som inhiberer proteolytiske enzymer
EP1283054A4 (en) MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
ES2191066T3 (es) Preparacion enantioselectiva de sulfoxidos farmaceuticamente activos por biooxidacion.
MXPA05008489A (es) Procedimiento de fabricacion para preparaciones liposomicas.
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
BR0303367A (pt) Células de mycobacterium w, veìculo farmaceuticamente aceitável, preservativo, ruptura de mycobacterium w, extração de solvente, enzimas usadas para a extração enzimática de células de mycobacterium w, adjuvante, composição farmacêutica, tensoativo, e, concentração de tensoativo do processo de fabricar uma composição farmacêutica para a administração de tuberculose
BR0312152A (pt) método de produção de lipossomos contendo um composto biologicamente ativo, e composição de lipossomos
PT94882A (pt) Processo para a preparacao de arginina deiminase e de um agente anti-canceroso contendo esta enzima como ingrediente activo
WO2002009639A3 (en) Methods and pharmaceutical compositions for healing wounds
IL151359A0 (en) Esmolol formulation
CA2356959A1 (en) Water-insoluble drug delivery system
JPH05186338A (ja) （ｒ）−イソフルランおよび（ｒ）−デスフルランの使 用法および組成物
BR0008739A (pt) Composições de liberação controlada debeta-histina
DK0584126T3 (da) Lanolinderivater som penetrationsfremmende stoffer
SE9900496D0 (sv) Vaccine formulation
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
AU4113797A (en) Method of preparing (s) - or (r) -3,3,3-trifluoro-2-hydroxy-2- methylpropionic acid
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
PT1087759E (pt) Processo para a producao de um laminado compreendendo varias camadas individuais

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired